Intan Baru Prana Tbk. vs Merck Tbk. — how do they compare? Intan Baru Prana Tbk. trades at Rp63 (market cap 103.18B, 799.4K 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Merck Tbk. is far larger — about 17.1× Intan Baru Prana Tbk.'s market cap, and Intan Baru Prana Tbk. is more actively traded (799.4K versus 63K). Which is the better fit depends on your goals.
| IBFN | MERK | |
|---|---|---|
Market Cap | 103.18B | 1.76T |
Volume | 799.4K | 63K |
Lot | 7.99K | 630 |
Turnover | — | 243.97M |
Average Price | — | 3,872.46 |
Value | — | 243.97M |
Indicative Equilibrium Price | — | 3,900 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Intan Baruprana Finance Tbk (the Company) was established based on Notarial Deed No. 19 dated September 4, 1991 and amended by Notarial Deed No. 121 dated June 16, 1993 of Esther Daniar Iskandar, S.H., notary in Jakarta. The Company started its commercial operations in 1997. The Company is part of the Intraco Penta group of companies.
Read more on IBFN →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →